pyrroles has been researched along with losartan potassium in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 6 (60.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bell, LL; Cheung, JY; Lynch, CJ; Miller, BA | 1 |
Clark, AL; Cleland, JG; Coletta, AP; Loh, PH; Tin, L | 1 |
Cortes, JE; Estrov, Z; Gaikwad, A; Kantarjian, HM; Manshouri, T; Nussenzveig, RH; Prchal, J; Quintás-Cardama, A; Verstovsek, S | 1 |
Chiang, CK; Hsu, SP; Huang, JW; Hung, KY; Pai, MF; Peng, YS; Wu, KD; Yang, SY | 1 |
Boven, E; Broxterman, HJ; de Haas, RR; Haanen, JB; Hoekman, K; Kuik, DJ; Schuurhuis, GJ; van Cruijsen, H; van den Eertwegh, AJ; van der Veldt, AA; van Hinsbergh, VW; Verheul, HM; Vroling, L | 1 |
Dounousi, E; Ioannou, K; Kelesidis, A; Kotzadamis, N; Papakonstantinou, S; Tsakiris, D; Tsouchnikas, I; Xanthopoulou, K | 1 |
Gong, K; Li, T; Ning, X; Wang, X; Wu, P; Zhang, C; Zhang, N | 1 |
Brugarolas, J; Bruick, RK; Chang, J; Chen, W; Christie, A; Courtney, K; Frenkel, E; Gardner, KH; Geiger, H; Hao, G; Hill, H; Holloman, E; Homayoun, F; Hwang, TH; Josey, JA; Joyce, A; Kapur, P; Kim, MS; Ma, Y; McKay, RM; Patel, N; Pavia-Jimenez, A; Pedrosa, I; Reeves, C; Rizzi, JP; Sun, X; Wallace, EM; Wong, T; Xie, XJ; Xie, Y; Yell, P; Yousuf, Q; Zhang, H; Zojwalla, N | 1 |
Fu, X; Jiang, C; Li, H; Meng, Y; Tang, Y; Yan, F; Yu, L; Zhang, M | 1 |
1 trial(s) available for pyrroles and losartan potassium
Article | Year |
---|---|
Atorvastatin increases erythropoietin-stimulating agent hyporesponsiveness in maintenance hemodialysis patients: role of anti-inflammation effects.
Topics: Aged; Anemia; Atorvastatin; Drug Synergism; Erythropoietin; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Prospective Studies; Pyrroles; Recombinant Proteins; Renal Dialysis; Tumor Necrosis Factor-alpha | 2009 |
9 other study(ies) available for pyrroles and losartan potassium
Article | Year |
---|---|
Erythropoietin modulation of intracellular calcium: a role for tyrosine phosphorylation.
Topics: Adult; Alkaloids; Analog-Digital Conversion; Biological Transport; Bucladesine; Calcium; Carbazoles; Cyclic AMP-Dependent Protein Kinases; Erythroid Precursor Cells; Erythropoietin; Genistein; Humans; Image Processing, Computer-Assisted; Indoles; Intercellular Signaling Peptides and Proteins; Intracellular Fluid; Isoflavones; Isoquinolines; Naphthalenes; Peptides; Phosphorylation; Polycyclic Compounds; Protein Kinase C; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Pyrroles; Signal Transduction; Staurosporine; Sulfonamides; Tetradecanoylphorbol Acetate; Videotape Recording; Wasp Venoms | 1994 |
Recent changes to FDA-approved labeling.
Topics: Acetamides; Aminoquinolines; Atazanavir Sulfate; Atorvastatin; Botulinum Toxins, Type A; Dosage Forms; Drug Labeling; Epoetin Alfa; Erythropoietin; Heptanoic Acids; Humans; Imiquimod; Insulin; Insulin Lispro; Mandelic Acids; Oligopeptides; Oseltamivir; Pyridines; Pyrroles; Recombinant Proteins; United States; United States Food and Drug Administration | 2004 |
Clinical trials update from the European Society of Cardiology heart failure meeting: TNT subgroup analysis, darbepoetin alfa, FERRIC-HF and KW-3902.
Topics: Anemia; Atorvastatin; Cardiology; Clinical Trials as Topic; Congresses as Topic; Darbepoetin alfa; Diuretics; Erythropoietin; Europe; Exercise Tolerance; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Societies, Medical; Xanthines | 2006 |
The JAK kinase inhibitor CP-690,550 suppresses the growth of human polycythemia vera cells carrying the JAK2V617F mutation.
Topics: Animals; Apoptosis; Blotting, Western; Bone Marrow; Cell Cycle; Cell Nucleus; Cell Proliferation; Cells, Cultured; Erythroid Precursor Cells; Erythropoietin; Flow Cytometry; Humans; Immunoprecipitation; Janus Kinase 2; Membrane Potential, Mitochondrial; Mice; Mutation; Phosphorylation; Piperidines; Polycythemia Vera; Protein Kinase Inhibitors; Protein Transport; Pyrimidines; Pyrroles; Receptors, Erythropoietin; Signal Transduction; STAT3 Transcription Factor | 2008 |
Increased numbers of small circulating endothelial cells in renal cell cancer patients treated with sunitinib.
Topics: Adult; Aged; Aged, 80 and over; Antigens, CD34; Antineoplastic Agents; Biomarkers, Tumor; Blood Cell Count; Carcinoma, Renal Cell; Endothelial Cells; Erythropoietin; Female; Flow Cytometry; Hematopoietic Stem Cells; Humans; Indoles; Kidney Neoplasms; Kinetics; Male; Middle Aged; Pyrroles; Sunitinib; Treatment Outcome; Vascular Endothelial Growth Factor A | 2009 |
Beneficial effect of atorvastatin on erythropoietin responsiveness in maintenance haemodialysis patients.
Topics: Aged; Atorvastatin; C-Reactive Protein; Cholesterol, LDL; Erythropoietin; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prospective Studies; Pyrroles; Renal Dialysis | 2009 |
The erythropoietin/erythropoietin receptor signaling pathway promotes growth and invasion abilities in human renal carcinoma cells.
Topics: Animals; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Erythropoietin; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Indoles; Kidney Neoplasms; Matrix Metalloproteinase 2; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Protein Kinase Inhibitors; Pyrroles; Receptors, Erythropoietin; Recombinant Proteins; Signal Transduction; Sunitinib | 2012 |
Targeting renal cell carcinoma with a HIF-2 antagonist.
Topics: Animals; Aryl Hydrocarbon Receptor Nuclear Translocator; Basic Helix-Loop-Helix Transcription Factors; Binding Sites; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Transformation, Neoplastic; Drug Resistance, Neoplasm; Erythropoietin; Female; Gene Expression Regulation, Neoplastic; Humans; Indans; Indoles; Kidney Neoplasms; Male; Mice; Mice, Inbred NOD; Mice, SCID; Molecular Targeted Therapy; Mutation; Pyrroles; Reproducibility of Results; Sulfones; Sunitinib; Xenograft Model Antitumor Assays | 2016 |
Erythropoietin improves hypoxic-ischemic encephalopathy in neonatal rats after short-term anoxia by enhancing angiogenesis.
Topics: Angiogenesis Inducing Agents; Animals; Animals, Newborn; Cognition; Disease Models, Animal; Erythropoietin; Hippocampus; Hypoxia; Hypoxia-Ischemia, Brain; Indoles; Male; Pyrroles; Random Allocation; Rats, Sprague-Dawley; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; White Matter | 2016 |